Herrlinger, Ulrich ; Schäfer, Niklas ; Steinbach, Joachim P. 
; Weyerbrock, Astrid ; Hau, Peter ; Goldbrunner, Roland ; Friedrich, Franziska ; Rohde, Veit ; Ringel, Florian ; Schlegel, Uwe ; Sabel, Michael ; Ronellenfitsch, Michael W. ; Uhl, Martin ; Maciaczyk, Jaroslaw ; Grau, Stefan ; Schnell, Oliver ; Hänel, Mathias ; Krex, Dietmar ; Vajkoczy, Peter ; Gerlach, Rüdiger ; Kortmann, Rolf-Dieter ; Mehdorn, Maximilian ; Tüttenberg, Jochen ; Mayer-Steinacker, Regine ; Fietkau, Rainer ; Brehmer, Stefanie ; Mack, Frederic ; Stuplich, Moritz ; Kebir, Sied ; Kohnen, Ralf ; Dunkl, Elmar ; Leutgeb, Barbara ; Proescholdt, Martin ; Pietsch, Torsten ; Urbach, Horst ; Belka, Claus ; Stummer, Walter ; Glas, Martin
; Weyerbrock, Astrid ; Hau, Peter ; Goldbrunner, Roland ; Friedrich, Franziska ; Rohde, Veit ; Ringel, Florian ; Schlegel, Uwe ; Sabel, Michael ; Ronellenfitsch, Michael W. ; Uhl, Martin ; Maciaczyk, Jaroslaw ; Grau, Stefan ; Schnell, Oliver ; Hänel, Mathias ; Krex, Dietmar ; Vajkoczy, Peter ; Gerlach, Rüdiger ; Kortmann, Rolf-Dieter ; Mehdorn, Maximilian ; Tüttenberg, Jochen ; Mayer-Steinacker, Regine ; Fietkau, Rainer ; Brehmer, Stefanie ; Mack, Frederic ; Stuplich, Moritz ; Kebir, Sied ; Kohnen, Ralf ; Dunkl, Elmar ; Leutgeb, Barbara ; Proescholdt, Martin ; Pietsch, Torsten ; Urbach, Horst ; Belka, Claus ; Stummer, Walter ; Glas, Martin Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial
Herrlinger, Ulrich, Schäfer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W. , Uhl, Martin, Maciaczyk, Jaroslaw, Grau, Stefan, Schnell, Oliver, Hänel, Mathias, Krex, Dietmar, Vajkoczy, Peter, Gerlach, Rüdiger, Kortmann, Rolf-Dieter, Mehdorn, Maximilian, Tüttenberg, Jochen, Mayer-Steinacker, Regine, Fietkau, Rainer, Brehmer, Stefanie, Mack, Frederic, Stuplich, Moritz, Kebir, Sied, Kohnen, Ralf, Dunkl, Elmar, Leutgeb, Barbara, Proescholdt, Martin, Pietsch, Torsten, Urbach, Horst, Belka, Claus, Stummer, Walter and Glas, Martin
(2016)
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial.
Journal of Clinical Oncology 34 (14), pp. 1611-1619.
Date of publication of this fulltext: 17 Mar 2020 11:26
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Journal of Clinical Oncology | ||||
| Publisher: | AMER SOC CLINICAL ONCOLOGY | ||||
|---|---|---|---|---|---|
| Place of Publication: | ALEXANDRIA | ||||
| Volume: | 34 | ||||
| Number of Issue or Book Chapter: | 14 | ||||
| Page Range: | pp. 1611-1619 | ||||
| Date | 2016 | ||||
| Institutions | Medicine > Lehrstuhl für Neurologie | ||||
| Identification Number |
| ||||
| Keywords | ENDOTHELIAL GROWTH-FACTOR; PHASE-II; RECURRENT GLIOBLASTOMA; ADJUVANT TEMOZOLOMIDE; STANDARD TREATMENT; MALIGNANT GLIOMA; OPEN-LABEL; GENE; RADIOTHERAPY; CONCOMITANT; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 42209 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric